Skip to content

Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment

Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00731159
Enrollment
50
Registered
2008-08-08
Start date
2008-07-31
Completion date
2009-07-31
Last updated
2008-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sperm Capacitation

Brief summary

Our aim is to evaluate the potential of a new laboratory method that measure sperm capacitation to predict fertilization of oocytes in patients that undergo IVF treatments

Detailed description

Capacitation is a physiologic process in which the sperm acquire the potential to fertilize oocytes. Capacitation can be measured, but the available technics are expensive, inaccurate and complex. A new method to evaluate sperm capacitation was developed in Bar Ilan University, Israel. We intend to measure the capacitation of semen that is used for fertilizing human oocytes in patients treated at the IVF unit at Assaf Harofeh Medical Center.By this, to evaluate the potential of the new method to predict human oocyte fertilization.If the method will be found valuable, it will enable to develop new drugs/methods that may improve sperm capacitation and by this to improve oocyte fertilization leading to more embryos, pregnancies and deliveries.

Interventions

BIOLOGICALsperm capacitation

sperm capacitation measured at Bar Ilan University

OTHERbiologic

sperm synthesis of G-actine to F-actine

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients requiring IVF within the routine work of an IVF Unit * normo-responding woman * non ICSI cycles

Exclusion criteria

* Patients undergoing ICSI only cycle * Low responders-less than 8 oocytes * Male patients with low semen volume

Design outcomes

Primary

MeasureTime frame
Fertilization rate of human oocytes in thr routine IVF Laboratory workOne year

Countries

Israel

Contacts

Primary Contactarieh raziel, prof
araziel@asaf.health.gov.il97289779005
Backup Contactraphael ron-el, prof
rronel@asaf.health.gov.il97289779005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026